| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology, New York Medical, Valhalla, NY, USA
* To whom correspondence should be addressed. E-mail: alberto_nasjletti{at}nymc.edu.
Heme oxygenase (HO)-derived carbon monoxide (CO) attenuates vascular reactivity to constrictor stimuli. Angiotensin II (Ang II) produces vasoconstriction and induces HO-1 isoform expression. But, direct evidence that Ang II promotes HO product generation is lacking. Therefore, we examined the effects of Ang II on CO release and HO isoform expression in isolated rat kidneys. Kidneys were perfused with oxygenated Krebs buffer. Ang II (1 µmol/L) increased (P<0.05) perfusion pressure from 97±9 to 150±14 mmHg; it also increased (P<0.05) the concentration of CO in the venous effluent (from 27.1±11.9 to 45.6±11.7, 62.5±16.7, 94.8±20.7 and 101.9±13.1 nmol/L after 30, 60, 90, and 120 min, respectively). The pressor effect of Ang II was blunted (P<0.05) in kidneys perfused with buffer containing losartan (10 µmol/L) or protein kinase C (PKC) inhibitors staurosporine (0.1 µmol/L) or calphostin C (1 µmol/L). Kidneys perfused with buffer containing Ang II for 120 min also displayed increased (P<0.05) HO-1 expression. Stannous mesoporphyrin (30 µmol/L) decreased CO release (P<0.05) in preparations perfused with and without Ang II; the HO inhibitor also increased (P<0.05) perfusion pressure, more so in kidneys perfused with that without Ang II. We conclude that Ang II stimulates CO production and release in isolated perfused rat kidneys. This action of Ang II is linked to the activation of AT1 receptors and involves PKC activation and upregulation of renal HO-1 but not of HO-2 protein expression. The study suggests upregulation of renal HO-1 and CO release are protagonic events in a counter-regulatory mechanism that attenuates Ang II-induced renal vasoconstriction.
This article has been cited by other articles:
|
|
 |
|
  Y. Ren, M. A. D'Ambrosio, H. Wang, R. Liu, J. L. Garvin, and O. A. Carretero Heme oxygenase metabolites inhibit tubuloglomerular feedback (TGF) Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1207 - F1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vera, S. Kelsen, and D. E. Stec Kidney-Specific Induction of Heme Oxygenase-1 Prevents Angiotensin II Hypertension Hypertension, October 1, 2008; 52(4): 660 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Nath, L. V. d'Uscio, J. P. Juncos, A. J. Croatt, M. C. Manriquez, S. T. Pittock, and Z. S. Katusic An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H333 - H342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Kirkby and C. A. Adin Products of heme oxygenase and their potential therapeutic applications Am J Physiol Renal Physiol, March 1, 2006; 290(3): F563 - F571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. K. Johnson, R. A. Johnson, W. Durante, K. E. Jackson, B. K. Stevenson, and K. J. Peyton Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R601 - R608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
